Skip to main content

Table 4 Analysis of obstetric and health service factors associated with placental malaria

From: Predictors of placental malaria in Upper West Regional Hospital-Ghana

Characteristics

Placenta malaria

Crude OR (95 %CI)

p-value

No

Yes

  

IPT-SP

  < 3 doses

134(48.03)

16(76.19)

3.46(1.23–9.71)

0.018*

  ≥ 3 dosesa

145(51.97)

5(23.81)

1

 

Gravidity

  Primigravida

74(26.52)

13(61.90)

4.5(1.79–11.29)

< 0.0001*

  Multigravidaa

205(73.48)

8(38.10)

1

 

ITN use

  No

110(39.43)

12(57.14)

2.04(0.84–5.02)

0.117

  Usagea

169(60.57)

9(42.86)

1

 

IRS

  Not expose

50(17.92)

12(57.14)

6.1(2.44–15.27)

< 0.0001*

  Exposea

229(82.08)

9(42.86)

1

 

HIV status

  Negative

273(97.85)

20(95.24)

0.43(0.05–3.83)

0.457

  Positivea

6(2.15)

1(4.76)

1

 

ANC visits

  < 4 visits

23(8.24)

13(61.90)

18.08(6.79–48.13)

< 0.0001*

  ≥ 4 visitsa

256(91.76)

8(38.1)

1

 

Malaria in index pregnancy

  No

174(62.37)

6(28.57)

1

 

  Yes

105(37.63)

15(71.43)

4.1(1.56–11.01)

0.004*

Hypertension

  Normotension

275(98.57)

17(80.95)

1

 

  Hypertension

4(1.43)

3(19.05)

12.1(2.51–58.61)

0.002*

  1. *-P < 0.05- statistically significanta- reference group cOR Crude odds ratio